Inhibits antiviral activity induced by type I interferons. Does not block signal transduction of IFN, but is important to counter the host antiviral state induced by a pre-treatment with IFN. Plays a role in the inhibition of host NF-kappa-B activation by preventing the acetylation of the RELA/p65 subunit of NF-kappaB.